InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
T+90 hit rate
8%
T+90 mean return
-21.8%
Across 12 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Walker Karin L, Directeur Comptable. Insider active across 3 companies, notably Cyclacel Pharmaceuticals, Inc.. Cumulatively, 28 reports have been logged. Breakdown: 0 buy · 4 sells. Activity tracked since 15 June 2021. The latest transaction was filed on 24 January 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations28 total
5,000 shares@ US$13.533.0% of flowOrdinary Shares, par value $0.01 per shareSEC:0000905148-24-000282:0
5,000 shares@ US$13.532.9% of flowOrdinary Shares, par value $0.01 per shareSEC:0000905148-23-001682:0
5,000 shares@ US$13.532.9% of flowOrdinary Shares, par value $0.01 per shareSEC:0000905148-23-001531:0
5,000 shares@ US$13.533.0% of flowOrdinary Shares, par value $0.01 per shareSEC:0000905148-23-001201:0
5,000 shares@ US$15.043.7% of flowOrdinary Shares, par value $0.01 per shareSEC:0000905148-23-000946:0
5,000 shares@ US$15.043.3% of flowOrdinary Shares, par value $0.01 per shareSEC:0000905148-23-000772:0
5,000 shares@ US$15.043.2% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-23-035280:0
21,219 shares0Common StockSEC:0001104659-23-077655:0
5,000 shares@ US$15.043.3% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-23-030563:0
5,000 shares@ US$15.043.3% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-23-025833:0
5,000 shares@ US$15.043.3% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-23-019684:0
5,000 shares@ US$15.043.4% of flowOrdinary Shares, par value $0.01 per shareSEC:0001140361-23-013190:0
20,000 shares@ US$15.0413.3% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-23-005293:0
10,000 shares@ US$15.046.9% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-22-020647:0
20,000 shares@ US$15.0414.5% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-22-018818:0
15,822 shares0Common StockSEC:0001104659-22-071903:0
4,519 shares@ US$15.042.9% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-21-021197
4,519 shares@ US$15.040.012% mcap9.5% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-21-021197:0
20,000 shares@ US$15.0412.3% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-21-018621
20,000 shares@ US$15.040.050% mcap40.5% of flowOrdinary Shares, par value $0.01 per shareSEC:0001567619-21-018621:0
2,374 shares0Common StockSEC:0001104659-21-082598
2,374 shares0Common StockSEC:0001104659-21-082598:0
2,000 sharesOrdinary Shares, par value $0.01 per shareSEC:0000899243-16-011804:0
500 sharesOrdinary Shares, par value $0.01 per shareSEC:0000899243-16-011804:2
2,000 sharesOrdinary Shares, par value $0.01 per shareSEC:0000899243-16-011804:3
25 of 28 declarations
About Walker Karin L
Walker Karin L is the Chief Accounting Officer of Cyclacel Pharmaceuticals, Inc. and PROTHENA CORP PUBLIC LTD CO. She oversees the accounting operations of these companies, ensuring compliance and accuracy of financial reporting. Her role is essential for maintaining the financial health of the organization. Karin brings valuable expertise in accounting and financial management.
